ESC 365 - Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

ESC Premium Access

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

Session: Heart failure with mid-range and preserved ejection fraction

Topic: Diastolic dysfunction

Speaker: Doctor M. Gori (Bergamo, IT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Mauro Gori

Papa Giovanni XXIII Hospital, Bergamo (Italy)

1 presentation

0 follower

4 more presentations in this session

State of the Art: HFmrEF - The new middle child

Speaker: Professor R. De Boer (Rotterdam, NL)

Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

Speaker: Doctor G. Savarese (Stockholm, SE)

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

Should we abandon EF to stratify heart failure treatment?

Speaker: Professor S. Solomon (Boston, US)

Access the full session

Heart failure with mid-range and preserved ejection fraction

Speakers: Doctor M. Gori, Professor R. De Boer, Doctor G. Savarese, Doctor A. Aimo, Professor S. Solomon

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources